Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pentylenetetrazole (4 trials)
Iopofosine (1 trial)
Cataplexy (Phase 2)
Disorders of Excessive Somnolence (Phase 2)
Idiopathic Hypersomnia (Phase 2)
Narcolepsy (Phase 2)
Trials (5 total)
Trial APIs (2 total)